Tsumura: The Fiscal Year Ended March 31, 2025 Supplementary Materials
Tsumura: Notice Concerning Status of Share Repurchases
Tsumura: 2nd Medium-Term Management Plan (FY2025 - FY2027)
Tsumura: Notice regarding partial revision of the Performance-Based Stock Compensation System
Tsumura: Notice regarding the continuation of Trust-type Stock Delivery System for Employees
Tsumura: Consolidated Financial Results for the Fiscal Year Ended March 31, 2025
Tsumura: Second Mid-Term Management Plan (2025-2027)
Tsumura: Notice Concerning Partial Revisions to the Performance-Linked Stock Remuneration System
Tsumura: Notice regarding the continuation of the trust-type stock grant system to our employees
Tsumura: Notice Concerning Status of Share Repurchases
Tsumura: [Delayed](Progress of Disclosed Matters) Notice of Decision on Matters Relating to Purchase of Treasury Shares
Tsumura: [Delayed]Notice of Decision on Offer Price, etc.
Tsumura: [Delayed]Notice of Decision on Matters Relating to Purchase of Treasury Shares
Tsumura: [Delayed]Notice of Sale of Shares
Tsumura: [Delayed]Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2025(Completion of Interim review)
Tsumura: Tsumura Announces Revision of Earnings Forecast
Tsumura: The Third Quarter of the Term Ending March 31, 2025 Supplementary Materials
Tsumura: Consolidated Financial Results for the Third Quarter of the Term Ending March 31, 2025
Tsumura: Notice of signing of a letter of intent between Ping An Tsumura Co., Ltd. and Shanghai Hongqiao Pharmaceutical Co., Ltd.
Tsumura: Corporate Governance Report